Black Diamond Therapeutics, Inc. (BDTX) Form 10-Q Quarterly Reports
Black Diamond Therapeutics, Inc. (BDTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BDTX
CIK: 1701541
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerKaren Pfeil
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-21 | 2026-09-18 | 4 | 0001193125-26-396868 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-18 | 4 Filing | 0002018686-26-000014 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001701541-26-000025 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001701541-26-000023 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002206 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001897612-26-000526 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288598 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 Filing | 0001682019-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 Filing | 0001556064-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 Filing | 0002018686-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 Filing | 0001456849-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 Filing | 0002018966-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-26 | FORM 8-K | 0001104659-26-078847 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-19 | 4 | 0001193125-26-277553 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-19 | 4 Filing | 0002018686-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | FORM 8-K | 0001104659-26-065254 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001701541-26-000017 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001701541-26-000015 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001104659-26-051509 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001104659-26-051492 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-26 | DEF 14A | 0001104659-26-051474 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-20 | 4 | 0001193125-26-117938 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-20 | 4 Filing | 0002018686-26-000002 | View SEC Doc Filr Page |
| S-8 | 2026-03-16 | — | FORM S-8 | 0001104659-26-028461 | View SEC Doc Filr Page |
| 10-K | 2026-03-16 | 2025-12-31 | 10-K | 0001701541-26-000009 | View SEC Doc Filr Page |